Zhongping Cheng

1.7k total citations
72 papers, 1.2k citations indexed

About

Zhongping Cheng is a scholar working on Molecular Biology, Reproductive Medicine and Immunology. According to data from OpenAlex, Zhongping Cheng has authored 72 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Reproductive Medicine and 19 papers in Immunology. Recurrent topics in Zhongping Cheng's work include Endometriosis Research and Treatment (12 papers), Uterine Myomas and Treatments (12 papers) and Reproductive System and Pregnancy (8 papers). Zhongping Cheng is often cited by papers focused on Endometriosis Research and Treatment (12 papers), Uterine Myomas and Treatments (12 papers) and Reproductive System and Pregnancy (8 papers). Zhongping Cheng collaborates with scholars based in China, United States and Germany. Zhongping Cheng's co-authors include Ning Luo, Weihong Yang, Jing Guo, Guihai Ai, Xiaoyan Qu, Li Liu, Caixia Li, Hongwen Huang, Jie Liu and Lian Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Zhongping Cheng

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongping Cheng China 19 600 308 240 175 173 72 1.2k
Xiaofang Yi China 21 740 1.2× 355 1.2× 143 0.6× 202 1.2× 312 1.8× 67 1.4k
Manhua Cui China 18 591 1.0× 212 0.7× 194 0.8× 214 1.2× 131 0.8× 55 984
Judit Pallarés Spain 21 1.3k 2.1× 590 1.9× 298 1.2× 516 2.9× 193 1.1× 31 2.2k
Feng Xie China 23 682 1.1× 469 1.5× 403 1.7× 287 1.6× 156 0.9× 86 1.6k
Ashwini L. Chand Australia 22 753 1.3× 242 0.8× 329 1.4× 566 3.2× 219 1.3× 41 1.6k
Yanqing Li China 25 1.2k 2.0× 748 2.4× 171 0.7× 399 2.3× 56 0.3× 104 1.9k
Jung‐Yoon Yoo South Korea 22 638 1.1× 175 0.6× 647 2.7× 174 1.0× 662 3.8× 60 1.6k
Huan Yan China 21 763 1.3× 302 1.0× 176 0.7× 209 1.2× 32 0.2× 38 1.3k
Dongming Su China 22 969 1.6× 555 1.8× 299 1.2× 299 1.7× 31 0.2× 34 1.6k

Countries citing papers authored by Zhongping Cheng

Since Specialization
Citations

This map shows the geographic impact of Zhongping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongping Cheng more than expected).

Fields of papers citing papers by Zhongping Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongping Cheng. The network helps show where Zhongping Cheng may publish in the future.

Co-authorship network of co-authors of Zhongping Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongping Cheng. A scholar is included among the top collaborators of Zhongping Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongping Cheng. Zhongping Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiao & Zhongping Cheng. (2024). Oncolytic Viruses in Cancer Immunotherapy. Advanced Therapeutics. 7(7). 4 indexed citations
2.
Liu, Hailun, André Franken, Alexandra P. Bielfeld, et al.. (2024). Progesterone-induced progesterone receptor membrane component 1 rise-to-decline changes are essential for decidualization. Reproductive Biology and Endocrinology. 22(1). 20–20. 1 indexed citations
3.
Cheng, Zhongping, et al.. (2023). Expression of high-mobility group box-1 in eutopic/ectopic endometrium and correlations with inflammation-related factors in adenomyosis. Gynecological Endocrinology. 39(1). 2269265–2269265. 2 indexed citations
4.
Wu, Yuliang, Qi Liu, Sai Zhang, et al.. (2023). MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer. Journal of Ovarian Research. 16(1). 181–181. 17 indexed citations
5.
Huang, Wei, Yuliang Wu, Ning Luo, et al.. (2023). Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Frontiers in Molecular Biosciences. 10. 963639–963639. 10 indexed citations
6.
Liu, Hailun, et al.. (2022). Identifying Mitotic Kinesins as Potential Prognostic Biomarkers in Ovarian Cancer Using Bioinformatic Analyses. Diagnostics. 12(2). 470–470. 4 indexed citations
7.
Wu, Yuliang, Yutong Xie, Chunyan Wang, et al.. (2022). Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types. Frontiers in Molecular Biosciences. 9. 743515–743515. 13 indexed citations
8.
Shao, Xiaowen, Jinlong Qin, Jiajing Cheng, et al.. (2021). ADSC Exosomes Mediate lncRNA-MIAT Alleviation of Endometrial Fibrosis by Regulating miR-150-5p. Frontiers in Genetics. 12. 679643–679643. 26 indexed citations
9.
Chen, Li, et al.. (2020). Aspirin modulates STOX1 expression and reverses STOX1-induced insufficient proliferation and migration of trophoblast cells. Pregnancy Hypertension. 19. 170–176. 8 indexed citations
10.
Yang, Weihong, Li Liu, Caixia Li, et al.. (2018). TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway. Cell Death and Disease. 9(9). 908–908. 75 indexed citations
11.
Li, Caixia, Jing Guo, Ning Luo, et al.. (2017). Eutopic/ectopic endometrial apoptosis initiated by bilateral uterine artery occlusion: A new therapeutic mechanism for uterus-sparing surgery in adenomyosis. PLoS ONE. 12(4). e0175511–e0175511. 8 indexed citations
12.
Jiang, Caixia, Chao Liu, Jing Guo, et al.. (2017). CA125 modified by PLT and NLR improves the predictive accuracy of adenomyosis-derived pelvic dense adhesion. Medicine. 96(19). e6880–e6880. 10 indexed citations
13.
Yang, Weihong, et al.. (2017). Laparoscopic-based score assessment combined with a multiple disciplinary team in management of recurrent ovarian cancer. Medicine. 96(30). e7440–e7440. 3 indexed citations
14.
Luo, Ning, et al.. (2016). ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells. Cell Death and Disease. 7(3). e2157–e2157. 53 indexed citations
15.
Cheng, Zhongping, Jing Guo, Li Chen, et al.. (2015). Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells. Molecular Carcinogenesis. 55(6). 1048–1059. 34 indexed citations
16.
Guo, Jing, Li Chen, Ning Luo, et al.. (2015). Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells. Oncology Reports. 33(6). 3124–3130. 45 indexed citations
17.
Zhang, Ting, Zhengwen Ma, Ruili Wang, et al.. (2010). Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells. Cancer Immunology Immunotherapy. 59(7). 1097–1108. 30 indexed citations
18.
Cheng, Zhongping, Lizhen Xu, Yu Zhu, et al.. (2009). Laparoscopic Uterine Vessels Occlusion for the Treatment of Interstitial Pregnancy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 19(4). 509–512. 11 indexed citations
19.
Cheng, Zhongping. (2003). Comparison of Genetic Differences in Groups of Amygdalus persica Revealed by RAPD. 1 indexed citations
20.
Cheng, Zhongping, et al.. (2002). Analysis of Shouxingtao germplasm revealed by RAPD. Beijing Linye Daxue xuebao. 24(3). 74–77. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofang Yi Breakdown of academic impact, for papers by Manhua Cui Breakdown of academic impact, for papers by Judit Pallarés Breakdown of academic impact, for papers by Feng Xie Breakdown of academic impact, for papers by Ashwini L. Chand Breakdown of academic impact, for papers by Yanqing Li Breakdown of academic impact, for papers by Jung‐Yoon Yoo Breakdown of academic impact, for papers by Huan Yan Breakdown of academic impact, for papers by Dongming Su
Rankless by CCL
2026